炎症性肠病患者血液中减少的肠道来源CD4+/CD8α+调节性T细胞表达CCR6和CXCR6
研究从人结肠固有层和血液中分离表达CD4和CD8α的DP8α调节性T细胞,发现其响应普拉梭菌并表达CCR6和CXCR6。在106例炎症性肠病患者、12例感染性结肠炎患者和35例健康对照中,炎症性肠病患者外周血CCR6+/CXCR6+ DP8α T细胞比例显著降低(P < .0001)。以<7.875个/万CD3+细胞为阈值区分炎症性肠病与感染性结肠炎,特异性100%、敏感性72.2%。
要点
- 炎症性肠病患者血中CCR6+/CXCR6+ DP8α T细胞比例较感染性结肠炎和对照显著降低(P < .0001)。
- 该类细胞产生IL-10并通过CD39活性抑制T细胞增殖,具调节性T细胞特征。
- 阈值<7.875个/万CD3+细胞区分炎症性肠病与感染性结肠炎:特异性100%、敏感性72.2%。
核心结论
- 研究鉴定出一群肠道来源的调节性T细胞,其在炎症性肠病患者血液中较感染性结肠炎患者和对照减少。
- 作者认为这些细胞应进一步研究,以确定其减少的机制及其对炎症性肠病发病、预后或诊断价值的贡献。
研究设计与样本
- 从人结肠固有层和血液样本中分离DP8α T细胞,用流式细胞术检测结肠来源细胞标志。
- 在106例炎症性肠病患者、12例感染性结肠炎患者和35例健康供者(对照)的血样中定量表达结肠特异性标志的DP8α细胞。
- 用抗CD3刺激细胞,以酶联免疫吸附试验测定白细胞介素10产生,比较患者与对照的细胞频率和反应性。
主要发现
- 响应普拉梭菌(Faecalibacterium prausnitzii)的循环DP8α T细胞表达CCR6和CXCR6。
- 这些细胞具调节性T细胞特征,包括产生IL-10和通过CD39活性抑制T细胞增殖。
- 炎症性肠病患者CD3+ T细胞总群中循环CCR6+/CXCR6+ DP8α T细胞比例较感染性结肠炎患者或对照显著降低(P < .0001)。
- 以<7.875个CCR6+/CXCR6+ DP8α T细胞/10,000个CD3+细胞为阈值,区分炎症性肠病与感染性结肠炎的特异性为100%、敏感性为72.2%。
关键数值与推荐
- 区分炎症性肠病与感染性结肠炎的阈值为<7.875个CCR6+/CXCR6+ DP8α T细胞/10,000个CD3+细胞,特异性100%、敏感性72.2%。
临床怎么用
- 原文未据此给出推荐。
局限性
- 作者在结论中提出这些细胞应进一步研究,以确定其减少的机制及其对炎症性肠病发病、预后或诊断价值的贡献。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Faecalibacterium prausnitzii, a member of the Clostridium IV group of the Firmicutes phylum that is abundant in the intestinal microbiota, has anti-inflammatory effects. The relative level of F prausnitzii is decreased in fecal samples from patients with inflammatory bowel diseases (IBDs) compared with healthy individuals. Reduced F prausnitzii was correlated with relapse of Crohn's disease after surgery. We identified, in human colonic mucosa and blood, a population of T regulatory type 1-like T regulatory (TREG) cells that express CD4 and CD8α (DP8α T cells) and are specific for F prausnitzii. We aimed to determine whether they are altered in patients with IBD. METHODS: We isolated DP8α T cells from human colon lamina propria and blood samples and used flow cytometry to detect markers of cells that are of colon origin. We quantified DP8α cells that express colon-specific markers in blood samples from 106 patients with IBD, 12 patients with infectious colitis, and 35 healthy donors (controls). We identified cells that respond to F prausnitzii. Cells were stimulated with anti-CD3, and their production of interleukin 10 was measured by enzyme-linked immunosorbent assay. We compared the frequency and reactivity of cells from patients vs controls using the 2-sided Student t test or 1-way analysis of variance. RESULTS: Circulating DP8α T cells that proliferate in response to F prausnitzii express the C-C motif chemokine receptor 6 (CCR6) and C-X-C motif chemokine receptor 6 (CXCR6). These cells also have features of TREG cells, including production of IL-10 and inhibition of T-cell proliferation via CD39 activity. The proportion of circulating CCR6+/CXCR6+ DP8α T cells was significantly reduced (P < .0001) within the total population of CD3+ T cells from patients with IBD compared with patients with infectious colitis or controls. A threshold of <7.875 CCR6+/CXCR6+ DP8α T cells/10,000 CD3+ cells discriminated patients with IBD from those with infectious colitis with 100% specificity and 72.2% sensitivity. CONCLUSIONS: We identified a population of gut-derived TREG cells that are reduced in blood samples from patients with IBD compared with patients with infectious colitis or controls. These cells should be studied further to determine the mechanisms of this reduction and how it might contribute to the pathogenesis of IBD and their prognostic or diagnostic value.
引用
- Godefroy E, Alameddine J, Montassier E, et al. Expression of CCR6 and CXCR6 by Gut-Derived CD4+/CD8α+ T-Regulatory Cells, Which Are Decreased in Blood Samples From Patients With Inflammatory Bowel Diseases. Gastroenterology. 2018. PMID: 29981781. doi:10.1053/j.gastro.2018.06.078
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。